Triple-negative breast cancer (TNBC) is a molecularly heterogeneous subgroup of BC that is characterized by negative expression for three biomarkers namely estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor-2 (HER-2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.